drugset / Trial / NCT03807739

A Study to Determine the Bioavailability of Various Formulations of GDC-0134 in Healthy Female Participants of Non-Childbearing Potential

NCT03807739

Phase 1 Completed 38 enrolled Genentech, Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

This is a two-part study to determine the relative bioavailability of two different prototype capsules of GDC-0134 to that of an existing reference capsule of GDC-0134 under both fed and fasted conditions. The study is open to healthy female participants of non-childbearing potential.

Timeline

Start
2019-02-01
Primary completion
2019-05-30
Completion
2019-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject GDC-0134 Small molecule Oral

Indications

No indication recorded.